Kalshi introduces prediction markets for clinical trials, FDA approvals
statnews.com · 274 words · saved by 1 readers
Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.
Company touts an approach it believes can provide benefits and minimize risks to the field Martin LELIEVRE / AFP via Getty Images By Elaine Chen July 16, 2026 Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech. Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine…
saved by
related reading
- America Must Address Early Clinical Developmentfda.gov
- Wisdom of the crowd | Naturenature.com
- From prediction markets to info financevitalik.eth.limo
- Creating prediction markets (and suing the CFTC) with Tarek Mansour and Luana Lopes Laracheekypint.substack.com
- Prediction market - Wikipediaen.wikipedia.org
- The Prediction Markets Opportunity – Part 1: From Experiments to Exchanges - Tower Research Capitaltower-research.com
- SKIN IN THE GAME OR STFUterminallyonchain.xyz
- Why prediction markets matter - a16z cryptoa16zcrypto.com
- The perils of election prediction marketsgoodauthority.org
- Curious cases of financial engineering in biotechowlposting.com
- Are Prediction Markets Good for Anything?—Asteriskasteriskmag.com
- The Financialisation of Having Opinions 🔮thetokendispatch.com